Houkai Li

6.2k total citations · 1 hit paper
76 papers, 4.0k citations indexed

About

Houkai Li is a scholar working on Molecular Biology, Physiology and Epidemiology. According to data from OpenAlex, Houkai Li has authored 76 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Molecular Biology, 22 papers in Physiology and 20 papers in Epidemiology. Recurrent topics in Houkai Li's work include Gut microbiota and health (35 papers), Metabolomics and Mass Spectrometry Studies (21 papers) and Liver Disease Diagnosis and Treatment (19 papers). Houkai Li is often cited by papers focused on Gut microbiota and health (35 papers), Metabolomics and Mass Spectrometry Studies (21 papers) and Liver Disease Diagnosis and Treatment (19 papers). Houkai Li collaborates with scholars based in China, United States and Macao. Houkai Li's co-authors include Wei Jia, Junli Ma, Jeremy K. Nicholson, Liping Zhao, Lili Sheng, He Jiaojiao, Ningning Zheng, Yunping Qiu, Guoxiang Xie and Xiaojiao Zheng and has published in prestigious journals such as SHILAP Revista de lepidopterología, Nature Reviews Drug Discovery and Diabetes.

In The Last Decade

Houkai Li

72 papers receiving 3.9k citations

Hit Papers

Desulfovibrio vulgaris, a potent acetic acid-producing ba... 2021 2026 2022 2024 2021 50 100 150 200

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Houkai Li China 33 2.6k 1.1k 858 341 306 76 4.0k
Abdullah Shaito Qatar 22 2.2k 0.8× 948 0.9× 401 0.5× 318 0.9× 161 0.5× 61 4.2k
Yan Yang China 39 2.1k 0.8× 617 0.6× 646 0.8× 548 1.6× 212 0.7× 218 5.3k
Xiaojiao Zheng China 40 3.2k 1.2× 1.3k 1.1× 1.2k 1.4× 321 0.9× 255 0.8× 98 5.3k
Long Yi China 37 2.4k 0.9× 1.2k 1.1× 985 1.1× 418 1.2× 190 0.6× 95 4.9k
Bina Joe United States 37 2.7k 1.0× 1.5k 1.4× 405 0.5× 598 1.8× 212 0.7× 181 5.6k
Chih‐Jung Chang Taiwan 24 2.4k 0.9× 921 0.8× 371 0.4× 211 0.6× 287 0.9× 60 3.9k
Leonilde Bonfrate Italy 29 1.4k 0.5× 768 0.7× 830 1.0× 361 1.1× 161 0.5× 74 3.4k
Fermín Sánchez de Medina Spain 41 2.6k 1.0× 703 0.6× 543 0.6× 448 1.3× 389 1.3× 126 5.7k
María Victoria García‐Mediavilla Spain 28 1.6k 0.6× 809 0.7× 1.3k 1.5× 597 1.8× 274 0.9× 43 3.7k

Countries citing papers authored by Houkai Li

Since Specialization
Citations

This map shows the geographic impact of Houkai Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Houkai Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Houkai Li more than expected).

Fields of papers citing papers by Houkai Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Houkai Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Houkai Li. The network helps show where Houkai Li may publish in the future.

Co-authorship network of co-authors of Houkai Li

This figure shows the co-authorship network connecting the top 25 collaborators of Houkai Li. A scholar is included among the top collaborators of Houkai Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Houkai Li. Houkai Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tang, Qun, Xiaoyang Wang, Chunmei Wang, et al.. (2025). Discovery of 3,4-dihydropyrimidine derivatives as novel Anti-PEDV agents targeting viral internalization through a unique calcium homeostasis disruption mechanism. European Journal of Medicinal Chemistry. 291. 117637–117637.
2.
Bao, Yiyang, Wenjing Wei, Xuefei Yu, et al.. (2025). Aged Gut Microbiota Contributes to Cognitive Impairment and Hippocampal Synapse Loss in Mice. Aging Cell. 24(7). e70064–e70064. 4 indexed citations
3.
Wu, Gaosong, Yuhao Zhang, Jing Zhao, et al.. (2024). Shexiang Baoxin Pill enriches Lactobacillus to regulate purine metabolism in patients with stable coronary artery disease. Phytomedicine. 130. 155727–155727. 1 indexed citations
4.
5.
Zheng, Ningning, Hao Wang, Weize Zhu, Yan Li, & Houkai Li. (2023). Astragalus polysaccharide attenuates nonalcoholic fatty liver disease through THDCA in high-fat diet-fed mice. Journal of Ethnopharmacology. 320. 117401–117401. 23 indexed citations
6.
Wu, Gaosong, Yuhao Zhang, Ningning Zheng, et al.. (2023). Cold exposure promotes coronavirus infection by altering the gut microbiota and lipid metabolism to reduce host immunity. SHILAP Revista de lepidopterología. 3(4). 216–231.
7.
Zhang, Yuhao, Wendan Zhang, Jing Zhao, et al.. (2022). Different software processing affects the peak picking and metabolic pathway recognition of metabolomics data. Journal of Chromatography A. 1687. 463700–463700. 15 indexed citations
8.
Wu, Gaosong, Wendan Zhang, Ningning Zheng, et al.. (2022). Integrated microbiome and metabolome analysis reveals the potential therapeutic mechanism of Qing-Fei-Pai-Du decoction in mice with coronavirus-induced pneumonia. Frontiers in Cellular and Infection Microbiology. 12. 950983–950983. 19 indexed citations
9.
Song, Nixue, Dayun Lu, Gaosong Wu, et al.. (2022). Serum proteomic analysis reveals the cardioprotective effects of Shexiang Baoxin Pill and Suxiao Jiuxin Pill in a rat model of acute myocardial infarction. Journal of Ethnopharmacology. 293. 115279–115279. 15 indexed citations
10.
Gu, Yu, Tao-Fang Cheng, Jian Yang, et al.. (2022). A multiomics and network pharmacological study reveals the neuroprotective efficacy of Fu-Fang-Dan-Zhi tablets against glutamate-induced oxidative cell death. Computers in Biology and Medicine. 148. 105873–105873. 14 indexed citations
11.
Yan, Juan, Lili Sheng, & Houkai Li. (2021). Akkermansia muciniphila : is it the Holy Grail for ameliorating metabolic diseases?. Gut Microbes. 13(1). 1984104–1984104. 91 indexed citations
12.
Wu, Gaosong, Jing Zhong, Linlin Chen, et al.. (2020). Effects of the Suxiao Jiuxin pill on acute myocardial infarction assessed by comprehensive metabolomics. Phytomedicine. 77. 153291–153291. 14 indexed citations
13.
Wu, Gaosong, Weidong Zhang, & Houkai Li. (2019). Application of metabolomics for unveiling the therapeutic role of traditional Chinese medicine in metabolic diseases. Journal of Ethnopharmacology. 242. 112057–112057. 40 indexed citations
14.
Zheng, Ningning, Yu Gu, Ying Hong, et al.. (2019). Vancomycin pretreatment attenuates acetaminophen-induced liver injury through 2-hydroxybutyric acid. Journal of Pharmaceutical Analysis. 10(6). 560–570. 23 indexed citations
15.
Ma, Junli & Houkai Li. (2018). The Role of Gut Microbiota in Atherosclerosis and Hypertension. Frontiers in Pharmacology. 9. 1082–1082. 173 indexed citations
16.
Ma, Junli, et al.. (2018). Mechanistic and therapeutic advances in non-alcoholic fatty liver disease by targeting the gut microbiota. Frontiers of Medicine. 12(6). 645–657. 28 indexed citations
17.
Jiaojiao, He, et al.. (2016). Study on Anti-Obesity Effect and Modulation of Gut Microbiota by Astragalus Polysaccharides in Mice. 11(11). 2379–2384. 7 indexed citations
18.
Jiaojiao, He, Ke Wang, Ningning Zheng, et al.. (2015). Metformin suppressed the proliferation of LoVo cells and induced a time-dependent metabolic and transcriptional alteration. Scientific Reports. 5(1). 17423–17423. 38 indexed citations
19.
Qiu, Yunping, Guoxiang Cai, Bingsen Zhou, et al.. (2014). A Distinct Metabolic Signature of Human Colorectal Cancer with Prognostic Potential. Clinical Cancer Research. 20(8). 2136–2146. 142 indexed citations
20.
Li, Houkai, Mingmei Zhou, Aihua Zhao, & Wei Jia. (2009). Traditional Chinese medicine: balancing the gut ecosystem. Phytotherapy Research. 23(9). 1332–1335. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026